Skip to main content
Kevan Herold, MD, Endocrinology, New Haven, CT

KevanCliffordHeroldMD

Endocrinology New Haven, CT

Diabetes, Lipid Metabolism

Professor, Immunobiology, Yale University School of Medicine

Telehealth Available

Overview of Dr. Herold

Dr. Kevan Herold is an endocrinologist in New Haven, CT and is affiliated with Yale-New Haven Hospital. He received his medical degree from Sidney Kimmel Medical College at Thomas Jefferson University and has been in practice 38 years. Dr. Herold accepts several types of health insurance, listed below. He is one of 58 doctors at Yale-New Haven Hospital who specialize in Endocrinology. He has more than 100 publications and over 500 citings.

Education & Training

  • University of Chicago
    University of ChicagoFellowship, Endocrinology, Diabetes, and Metabolism, 1982 - 1986
  • Temple University Hospital
    Temple University HospitalResidency, Internal Medicine, 1979 - 1982
  • Sidney Kimmel Medical College at Thomas Jefferson University
    Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1979

Certifications & Licensure

  • CT State Medical License
    CT State Medical License 2006 - 2025
  • NY State Medical License
    NY State Medical License 1998 - 2025
  • IL State Medical License
    IL State Medical License 1982 - 1999
  • PA State Medical License
    PA State Medical License 1981 - 1986
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • A Call for Improved Reporting of Human Islet Characteristics in Research Articles  
    Steven E Kahn, Kevan C Herold, Maureen Gannon, Diabetologia
  • Identification and Analysis of Islet Antigen–Specific CD8+ T Cells with T Cell Libraries  
    Kevan C Herold, Andrea K Steck, The Journal of Immunology
  • Reprogramming Human T Cell Function and Specificity with Non-Viral Genome Targeting  
    Neil Romberg, Antoni Ribas, Michael R Lee, Ruby Yu, Gary M Kupfer, Julia Carnevale, Jonathan H Esensten, P Jonathan Li, Han Li, Kevan C Herold, Alexander Marson, Nature
  • Join now to see all

Lectures

  • Abnormal Neutrophil Signature in the Blood and Pancreas of Presymptomatic and Symptomatic Type 1 Diabetes 
    New Haven, CT - 6/15/2014

Press Mentions

  • In a 1st, Scientists Reversed Type 1 Diabetes by Reprogramming a Person's Own Fat Cells
    In a 1st, Scientists Reversed Type 1 Diabetes by Reprogramming a Person's Own Fat CellsOctober 31st, 2024
  • 5 Medical Advances That Will Change Patient Care
    5 Medical Advances That Will Change Patient CareMay 4th, 2023
  • Are We Proof That a New Drug to Stop Diseases like Arthritis and Type 1 Diabetes Really DOES Work?
    Are We Proof That a New Drug to Stop Diseases like Arthritis and Type 1 Diabetes Really DOES Work?April 3rd, 2023
  • Join now to see all

Grant Support

  • Human And Translational ImmunologyNational Institute Of Allergy And Infectious Diseases2010–2011
  • Type 1 Diabetes Trialnet: Clinical Center At Yale University (U01)National Institute Of Diabetes And Digestive And Kidney Diseases2009–2011
  • Yale Autoimmunity Center Of ExcellenceNational Institute Of Allergy And Infectious Diseases2009–2011
  • Administrative Core A, Component Of Yale Autoimmunity Center Of ExcellenceNational Institute Of Allergy And Infectious Diseases2009–2011
  • Innate And Adaptive Immune Responses In Pre-Type 1 DiabetesNational Institute Of Diabetes And Digestive And Kidney Diseases2010
  • Phase II Trial Of Hokt3gamma 1 (Ala-Ala) In Type 1 DiabetesNational Institute Of Diabetes And Digestive And Kidney Diseases2006–2010
  • Type 1 Diabetes Trialnet: Clinical Center At Columbia UniversityNational Institute Of Diabetes And Digestive And Kidney Diseases2007
  • Type 1 Diabetes Trialnet: Clin Ctr At Columbia Universi*National Institute Of Diabetes And Digestive And Kidney Diseases2006
  • Phase II Trial Of Hokt3gamma 1 (Ala-Ala) In IDDMNational Institute Of Diabetes And Digestive And Kidney Diseases2005
  • Islet Growth In NOD Mice Tolerant To Autoimmune DiabetesNational Institute Of Diabetes And Digestive And Kidney Diseases2005
  • Safety And PK Of Hokt3yl (Ala-Ala) In TidmNational Center For Research Resources2005
  • Islet Transplants With Renal AllograftsNational Center For Research Resources2005
  • Islet Growth In NOD Mice Tolerant To Autoimmune DiabetesNational Institute Of Diabetes And Digestive And Kidney Diseases2004–2005
  • Combination Of Anti-Cd3 And Ag-Specific ImmunotherapyNational Institute Of Diabetes And Digestive And Kidney Diseases2004–2005
  • Phase II Multiple Dose Treatment Of Type 1 Diabetes Mellitus With Hokt3gammalNational Center For Research Resources2004–2005
  • Hokt3yl(Ala-Ala) In New Onset Type 1 Diabetes MellitusNational Center For Research Resources2004–2005
  • Type 1 Diabetes Trialnet: Clin Ctr At Columbia Universi*National Institute Of Diabetes And Digestive And Kidney Diseases2002–2005
  • Phase I/II Trial Of Hokt3(1(Ala-Ala) In Type 1 DiabetesNational Institute Of Diabetes And Digestive And Kidney Diseases2000–2004
  • Hokt3yl (Ala Ala) In New Onset Type I Diabetes MellitusNational Center For Research Resources2000–2002
  • T Cell Activation And Repertoire In Insulin Dependent Diabetes / Anti CD40L TrialNational Institute Of Allergy And Infectious Diseases1999–2002
  • Type 1 Diabetes Trialnet:Columbia UniversityNational Institute Of Diabetes And Digestive And Kidney Diseases2001
  • Clinical Research Training In Immunosuppression And DiabNational Center For Research Resources2000
  • Diabetes Prevention Trial--Type I DiabetesNational Center For Research Resources1996–1997
  • Immunoregulation Of IDDMNational Institute Of Diabetes And Digestive And Kidney Diseases1995
  • Islet Cell Reactive T-Lymphocytes In DiabetesNational Institute Of Diabetes And Digestive And Kidney Diseases1994
  • Immune Mechanism For Preventing Autoimmune DiabetesNational Institute Of Diabetes And Digestive And Kidney Diseases1992–1994
  • Islet Cell Reactive T Lymphocytes In Murine DiabetesNational Institute Of Diabetes And Digestive And Kidney Diseases1990–1993

Professional Memberships

Insurance Accepted

  • Aetna Choice POS II
    Aetna HMO
    BCBS Blue Card PPO
    BCBS Illinois PPO
    CIGNA HMO
    CIGNA Open Access
    CIGNA PPO
    Connecticare FlexPOS
    GHI PPO
    Great West PPO
    Health Alliance PPO
    HIP of New York - Select PPO
    Multiplan PHCS PPO
    Multiplan PPO
    Oxford Health Freedom
    Oxford Health Liberty
    United Healthcare - Direct Choice Plus POS
    United Healthcare - Direct Options PPO
    Wellmark Alliance Select
  • Please verify your coverage with the provider's office directly when scheduling an appointment